IP Library Granted Patent US 8,067,555
Granted Patent B2
US 8,067,555 · App. 11/882,978 · Granted Nov 29, 2011

Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

Assignee: Sigma-Tau Research Switzerland S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,067,555
App. No.
11/882,978
Granted
Nov 29, 2011
Kind
B2
Abstract

Partially desulphated glycosaminoglycan derivatives are described, particularly heparin, and more particularly a compound of formula (I) where the U, R and R 1 groups have the meanings indicated in the description. These glycosaminoglycan derivatives have antiangiogenic and heparanase-inhibiting activity and are devoid of anticoagulant activity.

Claims (40)

1. A process for the preparation of a compound of formula (I)

where R and R 1 are an SO 3 or an acetyl residue;

X and X′ are a —CH 2 -D group, wherein D is hydroxyl;

n and m, which can be the same or different, may vary from 1 to 40; the sum of n+m ranges from 6 to 40; the m:n ratio ranges from 10:2 to 1:1, the symbol indicates that the units marked m and n are statistically distributed along the polysaccharide chain and are not necessarily in sequence,

comprising the following steps:

a) N-desulphation by solvolytic hydrolysis of sulphamino residues n DMSO:H 2 O 95:5 v:v at ambient temperature for a time ranging from 0.5 to 8 h, to give the total or partial elimination of sulphate groups at position 2 of the glucosamine residues;

b) N-acylation of said totally or partially desulphated groups at position 2 of the glucosamine residues by treatment in alkaline aqueous solution (pH 8-9) with an acylating agent, to give totally or partially acylated groups at position 2 of the glucosamine residues;

c) oxidation of the diols with sodium periodate, to yield the opening of the glycoside ring and the formation of two aldehyde groups per modified residue; and

d) reduction of said aldehyde groups to primary alcohol.

2. The method of claim 1 , further comprising acid hydrolysis of compounds obtained in step d) to obtain oligosaccharides corresponding to regular sequences.

3. A process for the preparation of a compound of formula (I):

where R and R 1 are an SO 3 or an acetyl residue;

X and X′ are a —CH 2 -D group, wherein D is hydroxyl;

n and m, which can be the same or different, may vary from 1 to 40; the sum of n+m ranges from 6 to 40; the m:n ratio ranges from 10:2 to 1:1, the symbol indicates that the units marked m and n are statistically distributed along the polysaccharide chain and are not necessarily in sequence,

comprising the following steps:

a) N-desulphation by solvolytic hydrolysis of sulphamino residues in DMSO:H 2 O 95:5 v:v at ambient temperature for a time ranging from 0.5 to 8 h to give the total or partial elimination of sulphate groups at position 2 of the glucosamine residues;

b) N-acylation of said totally or partially desulphated groups at position 2 of the glucosamine residues by treatment in alkaline aqueous solution (pH 8-9) with an acylating agent, to give totally or partially acylated groups at position 2 of the glucosamine residues;

c) oxidation of the diols with sodium periodate to yield the opening of the glycoside ring and the formation of two aldehyde groups per modified residue;

d) reduction of said aldehyde groups to primary alcohol; and

e) submitting the products obtained in step d) to partial enzymatic hydrolysis with an enzyme selected from the group consisting of lyase, heparinase, heparitinase, or equivalent of to yield oligosaccharides, with non-reducing terminal residue consisting of unsaturated iduronic acid, the reducing residue consisting of an N-sulphoglucosamine and containing at least one residue of open iduronic acid.

4. The method of claim 3 , wherein said oligosaccharides are tetra or octa-saccharides.

5. A process for the preparation of a compound of formula (I):

where R and R 1 are an acetyl residue;

n and m which can be the same or different, may vary from 1 to 40; the sum of n+m ranges from 6 to 40; the m:n ratio ranges from 10:2 to 1:1, the symbol indicates that the units marked m and n are statistically distributed along the polysaccharide chain and are not necessarily in sequence,

comprising the following steps:

a) N-desulphation by solvolytic hydrolysis of sulphamino residues in DMSO:H 2 O 95:5 v:v at ambient temperature for a time ranging from 0.5 to 8 h to give the total elimination of sulphate groups at position 2 of the glucosamine residues;

b) N-acylation of said totally desulphated groups at position 2 of the glucosamine residues by treatment in alkaline aqueous solution (pH 8-9) with an acylating agent, to give totally acylated groups at position 2 of the glucosamine residues;

c) oxidation of the diols with sodium periodate, to yield the opening of the glycoside ring and the formation of two aldehyde groups per modified residue; and

d) reduction said aldehyde groups to primary alcohol.

6. The process of claim 5 further comprising acid hydrolyzing compounds obtained in step d) to obtain oligosaccharides corresponding to regular sequences.

7. A process for the preparation of a compound of formula (I):

where R and R 1 are an acetyl residue;

n and m, which can be the same or different, may vary from 1:40; the sum of n+m ranges from 6 to 40; the m:n ratio ranges from 10:2 to 1:1, the symbol indicates that the unit marked m and n are statistically distributed along the polysaccharide chain and are not necessarily in sequence,

comprising the following steps:

a) N-desulphation by solvolytic hydrolysis of sulphamino residues in DMSO:H 2 O 95:5 v:v at ambient temperature for a time ranging from 0.5 to 8 h, to give the total elimination of sulphate groups at position 2 of the glucosamine residues;

b) N-acylation of said totally desulphated groups at position 2 of the glucosamine residues by treatment in alkaline aqueous solution (pH 8-9) with an acylating agent, to give totally acylated groups at position 2 of the glucosamine residues;

c) oxidation of the diols with sodium periodate, to yield the opening of the glycoside ring and the formation of two aldehyde groups per modified residue;

d) reduction of said aldehyde groups to primary alcohol; and

e) submission of the product obtained in step d) to partial enzymatic hydrolysis with an enzyme selected from the group consisting of lyase, heparinase, heparinitase, or equivalent of, to yield oligosaccharides, with the non-reducing terminal residue consisting of unsaturated iduronic acid, the reducing residue consisting of an N-sulphoglucosamine and containing at least one residue of open iduronic acid.

8. The method of claim 7 , wherein said oligosaccharides are tetra or octa saccharides.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jan 24, 2019
From: SIGMA TAU RESEARCH SWITZERLAND SA; LEADIANT BIOSCIENCES SA
To: LEADIANT BIOSCIENCES SA IN LIQUIDAZIONE
Reel/Frame 049689/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2008
From: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
To: SIGMA-TAU RESEARCH SWITZERLAND S.A.
Reel/Frame 020531/0898 →
Priority Claims (3)
IT RM00A0041 · Jan 25, 2000 · national
WO PCT/IT01/00034 · Jan 24, 2001 · international
WO PCT/IT01/00472 · Sep 12, 2001 · international
Continuity (6)
Division 11314736 · Dec 22, 2005
Continuation In Part 10489359 · Feb 2, 2005
Continuation In Part 11028512 · Jan 4, 2005
Continuation In Part 10967255 · Oct 19, 2004
Continuation In Part 10182185 · Jul 25, 2002
Related Publication 20080051567A1 · Feb 28, 2008